-28.6%
NOW vs GSK
+26.4%
-55.0%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.0% | -2.7% | -2.3% | -5.5% |
| 7D | -6.1% | -4.2% | -1.9% | -6.9% |
| 30D | +7.5% | -7.5% | +15.0% | +5.7% |
| 3M | +17.5% | -3.3% | +20.8% | +17.2% |
| 6M | +7.9% | -9.3% | +17.3% | +6.0% |
| YTD | -12.4% | +1.6% | -14.0% | -15.2% |
| 1Y | -28.6% | +25.5% | -54.1% | -30.5% |
| All | -28.6% | +26.4% | -55.0% | -30.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling